We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Real-time and Dynamic Monitoring of Virus-mediated Cytopathogenicity with Roche’s xCELLigence System
News

Real-time and Dynamic Monitoring of Virus-mediated Cytopathogenicity with Roche’s xCELLigence System

Real-time and Dynamic Monitoring of Virus-mediated Cytopathogenicity with Roche’s xCELLigence System
News

Real-time and Dynamic Monitoring of Virus-mediated Cytopathogenicity with Roche’s xCELLigence System

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Real-time and Dynamic Monitoring of Virus-mediated Cytopathogenicity with Roche’s xCELLigence System"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

To understand overall infectivity, virus progression and disease-onset it is important to perform a detailed examination of cytopathogenic effects. Depending on the type of virus and cells as well as the time point of infection different cytopathogenic effects might be observed.

One of the most common methods for measuring lysogenic/lytic activity of viruses is the plaque test, a labor-intensive end-point assay which cannot provide infotmation about the onset of cytopathic effects and the kinetics of the viral replication.

In a study of Spiegel et al. (Institut für Virologie, Universität Göttingen) the xCELLigence system from Roche Applied Science was used for testing of virus-mediated cytopathogenicity (Biochemica 3, 2008, in print).

The assay described addresses several of the limitations of e.g. a plaque test, and provides a facile, easy platform for identification and further characterization of virus-mediated cytopathic effects. Two cell types, “VeroE6” (kidney culture cells of African green monkey with deficiency of the interferon system) and “293” (human embryonic kidney culture cells with intact interferon system) were infected with Vesicular Stomatitis Virus (VSV).

The heart of each xCELLigence System is a micro-electronic biosensor which is built into each well of the standard 96 well E Plate microtiter plates. A cell which has contact with the sensor changes the electrical impedance between the microelectrodes. Effects influencing the status of the cells lead to changes in the impedance measurements and can therefore be detected in real time. Labelling of the cells, which can induce non-physiological changes in the cells, is not necessary. The system is label free and requires no reporters.

The cell-based assay system perfectly integrates micro electronics and cell biology and has a number of advantages in comparison to conventional cell analysis systems. It is suitable for uninterrupted monitoring of processes in living cells and for monitoring real-time kinetics. The system supplies a densely concentrated stream of information and shows sensitivity and reproducibility when monitoring the overall cell population of a cell culture.
Advertisement